Sponsor Pipeline

Starna Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Early Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07003178 A Study to Evaluate the Safety and Clinical Efficacy of STR-P004 Non Hodgkin Lymphoma Not Yet Recruiting
Not specified
NCT07245251 To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004 Acute Lymphobkastic Leukemia Not Yet Recruiting
NCT07363954 To Evaluate the Safety and Tolerability of STR-P004 for the Treatment of Immune-mediated… Autoimmune Diseases Not Yet Recruiting
NCT07655453 Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of… Relapsed/Refractory Autoimmune Diseases Not Yet Recruiting
Disease Areas
Get alerts when Starna Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free